A Novel Four-Gene Prognostic Signature as a Risk Biomarker in Cervical Cancer
Background. Cervical cancer (CC) is a major malignancy affecting women worldwide, with limited treatment options for patients with advanced disease. The aim of this study was to identify novel prognostic biomarkers for CC. Methods. RNA-Seq data from four Gene Expression Omnibus datasets (GSE5787, GS...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2020-01-01
|
Series: | International Journal of Genomics |
Online Access: | http://dx.doi.org/10.1155/2020/4535820 |